| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 08/07/1991 | CA2051434A1 Transformed shigella |
| 08/06/1991 | US5038198 Modular semiconductor power device |
| 08/06/1991 | US5037960 Inhibitor of protein synthesis, process for its isolation, its use and pharmaceutical compositions in which it is present |
| 08/06/1991 | US5037753 Feline t-lymphotropic lentivirus |
| 08/06/1991 | US5037742 Pseudorabies virus recombinants and their use in the production of proteins |
| 08/06/1991 | US5037650 Live combination vaccine |
| 08/06/1991 | US5037645 Immunization using antibodies specific to the indoleamine hapten |
| 08/06/1991 | CA1287447C Peptides useful in vaccination against enteroviruses |
| 08/06/1991 | CA1287446C2 Bicyclic compounds, their production and use |
| 08/06/1991 | CA1287311C Recombinant dna provided with hepatitis b virus gene, mammalian cells transformed with cloned viral dna, and production of hepatitis b virus proteins |
| 08/05/1991 | CA2009281A1 Anti-idiotype antibodies reactive with shared idiotypes expressed by human lymphomas and auto-antibodies |
| 08/03/1991 | WO1991011460A1 Hepatitis a vaccines |
| 08/03/1991 | CA2035386A1 Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses |
| 08/02/1991 | WO1991011464A1 Lipopolysaccharide binding opsonin and methods of use thereof |
| 08/02/1991 | CA2075298A1 Lipopolysaccharide binding opsonin and methods of use thereof |
| 08/01/1991 | WO1991011718A1 Assays and treatments for autoimmune diseases |
| 08/01/1991 | WO1991011198A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 08/01/1991 | DE4002521A1 Recombinant plasmids for pox virus transformation - contg. multifunctional DNA sequence cassette to facilitate cloning of foreign DNA |
| 08/01/1991 | CA2074525A1 Assays and treatments for autoimmune diseases |
| 08/01/1991 | CA2073963A1 Neutralizing and/or adcc mediating monoclonal hiv antibody |
| 08/01/1991 | CA2035200A1 Antibodies specifically recognizing somatotropin binding protein |
| 07/31/1991 | WO1991011462A2 Merosin, nucleic acids encoding, fragments and uses thereof |
| 07/31/1991 | EP0439095A2 Therapeutic antibody based fusion proteins |
| 07/31/1991 | EP0439077A2 Synthetic peptide compositions with immunoreactivities to antibodies to HTLV |
| 07/31/1991 | EP0439056A2 Coccidiosis vaccines |
| 07/31/1991 | EP0438803A2 Vaccines against cancer and infectious diseases |
| 07/31/1991 | CN1053360A Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfuction |
| 07/31/1991 | CA2074361A1 Merosin, nucleic acids encoding, fragments and uses thereof |
| 07/30/1991 | WO1991012019A1 Enzyme treated bcg vaccine and process therefor |
| 07/30/1991 | CA2035097A1 Liposome-containing intranasal vaccine formulation |
| 07/30/1991 | CA2035088A1 Human monoclonal antibodies for brain tumor diagnosis and therapy |
| 07/30/1991 | CA2034564A1 Recombinant plasmid |
| 07/30/1991 | CA1286989C Immunoamplifiers and related compositions |
| 07/27/1991 | WO1991011528A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | WO1991011199A1 Medicaments and methods for treating aids and arc employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2074512A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids-related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2073459A1 Medicaments and methods for treating acquired immune deficiency syndrome (aids) and aids related complex (arc) employing anti-carbohydrate antibodies and carbohydrate antigens |
| 07/27/1991 | CA2034768A1 Recombinant coccidiosis vaccines - 5-7 eimeria surface antigen |
| 07/26/1991 | WO1991011193A1 Method and compositions for inhibiting angiogenesis |
| 07/26/1991 | CA2074725A1 Method and compositions for inhibiting angiogenesis |
| 07/25/1991 | WO1991011194A1 Lfa-3 as a vaccine adjuvant |
| 07/25/1991 | WO1991010735A2 Human receptor of tsh. sequence coding for such receptor |
| 07/25/1991 | WO1991010722A2 Chimeric immunoglobulin for cd4 receptors |
| 07/25/1991 | WO1991010682A1 Proteins produced by human lymphocytes, dna sequence coding these proteins, and pharmaceutical and biological uses thereof |
| 07/25/1991 | WO1991010680A1 Tumor killing effects of enterotoxins and related compounds |
| 07/25/1991 | WO1991010676A1 Peptides utilizable for immunomodulation |
| 07/25/1991 | WO1991010426A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/25/1991 | CA2049931A1 Lfa-3 as a vaccine adjuvant |
| 07/25/1991 | CA2034737A1 Pharmaceutical preparation for the maturation of prothymocytes |
| 07/24/1991 | EP0438332A1 Peptides issued from the glycoprotein envelope of HIV virus, their uses for the detection of an infection due to these viruses and for the vaccination against AIDS |
| 07/24/1991 | EP0438312A2 Recombinant human anti-CD18 antibodies |
| 07/24/1991 | EP0438259A1 Conjugates of biologically stable polymers and polynucleotides for treating systemic lupus erythematosus |
| 07/24/1991 | EP0438102A1 Process for the production of antibodies |
| 07/24/1991 | EP0437687A2 Process for purification of a 69000 dalton antigenic protein from bordetella pertussis |
| 07/24/1991 | EP0437604A1 Recombinant poxvirus and streptococcal m protein vaccine |
| 07/24/1991 | EP0437505A1 Primitive cell colony stimulating factors and lymphohematopoietic progenitor cells |
| 07/24/1991 | EP0265468B1 Dispersion of lipidic spherules |
| 07/24/1991 | CA2008519A1 Method for the inhibition of cell-cell and cell-substratum interactions by the blocking of carbohydrate-carbohydrate interactions |
| 07/23/1991 | US5034519 Oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines |
| 07/23/1991 | US5034511 Variant of LAV viruses |
| 07/20/1991 | WO1991010657A1 New thiazole derivatives |
| 07/20/1991 | WO1991010656A1 Thiazole derivatives |
| 07/20/1991 | CA2074180A1 Thiazole derivatives |
| 07/20/1991 | CA2074175A1 Thiazole derivatives |
| 07/20/1991 | CA2034593A1 Recombinant human anti-cd18 antibodies |
| 07/20/1991 | CA2034574A1 Recombinant human anti-cd18 antibodies |
| 07/17/1991 | WO1991010742A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/17/1991 | EP0436717A1 Method of treatment with medical agents |
| 07/17/1991 | EP0436648A1 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 07/17/1991 | EP0436634A1 Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids |
| 07/17/1991 | EP0436622A1 Diagnostic test for hblv |
| 07/17/1991 | EP0436537A1 Recombinant cmv neutralizing proteins |
| 07/17/1991 | EP0179871B1 Method and cell line for continuous production of retroviruses (htlv-iii) related to aids |
| 07/17/1991 | CN1053010A Pharmaceutical preparation |
| 07/17/1991 | CA2073060A1 Monoclonal antibody specific for non-immunodominant epitope of hiv proteins |
| 07/16/1991 | US5032522 Method of making staphylococcus aureus vaccine |
| 07/16/1991 | US5032520 Poultry |
| 07/16/1991 | US5032405 Oral pharmaceutical composition for acid sensitive proteinaceous agents |
| 07/16/1991 | US5032401 Glucan drug delivery system and adjuvant |
| 07/16/1991 | US5032398 Selective modification of the catalytic subunit of pertussis toxin |
| 07/16/1991 | US5032397 Polypeptidic fractions inducing protective antibodies against malaria parasites and immunogenic compositions |
| 07/16/1991 | CA1286241C Live rabies vaccine |
| 07/16/1991 | CA1286226C Vaccine against mumps and process for its preparation |
| 07/13/1991 | WO1991010741A1 Generation of xenogeneic antibodies |
| 07/13/1991 | CA2050918A1 Generation of xenogeneic antibodies |
| 07/11/1991 | WO1991009967A1 Humanised antibodies |
| 07/11/1991 | WO1991009966A1 Cd4 specific recombinant antibody |
| 07/11/1991 | WO1991009958A2 Method of delivering molecules into eukaryotic cells |
| 07/11/1991 | WO1991009940A1 Stable formulation of viral neuraminidase |
| 07/11/1991 | WO1991009872A2 Hiv-1 env fragment fusion protein |
| 07/11/1991 | WO1991009870A1 Immunologically active proteines from borrelia burgdorferi, related test kits and vaccine |
| 07/11/1991 | WO1991009867A1 Mucin nucleotides |
| 07/11/1991 | WO1991009866A1 Papillomavirus (hpv63) probe, particularly for the in vitro diagnosis of papillomavirus infections, possibly accompanied by genital neoplasias, and products genetically and immunologically linked to this papillomavirus |
| 07/11/1991 | WO1991009625A1 Monoclonal antibodies which neutralize hiv-1 infection and their anti-idiotypes |
| 07/11/1991 | WO1991009624A1 Pharmaceutical compositions for the treatment of drug dependence |
| 07/11/1991 | WO1991009623A1 Diagnosis and treatment of diseases |
| 07/11/1991 | WO1991009621A1 PEPTIDE FRAGMENT COMPRISING A SEQUENCE FROM THE 28kDa PROTEIN OF SCHISTOSOMA MANSONI, AND VACCINATING AND/OR THERAPEUTIC COMPOSITIONS COMPRISING SAID FRAGMENT |
| 07/11/1991 | WO1991009619A1 Pharmaceutical compositions containing antigen-antibody complexes and uses therefor |
| 07/11/1991 | CA2072356A1 Diagnosis and treatment of diseases |
| 07/10/1991 | EP0435957A1 Dna damage-binding factor and uses therefor |